A system monitors an individual for conditions indicating a possibility of occurrence of irregular heart events. A database includes a plurality of combinations of at least a first signature and a second signature. A first portion of the plurality of combinations is associated with a normal heartbeat and a second portion of the plurality of combinations is associated with an irregular heart event. A wearable heart monitor that is worn on a body of the patient includes a heart sensor for generating a heart signal responsive to monitoring a beating of a heart of the individual. The monitor further includes a processor for receiving the heart signal from the heart sensor. The processor is configured to analyze the heart signal using a plurality of different processes. Each of the plurality of different processes generates at least one of the first signature and the second signature. The plurality of different processes provide a unique combination including at least the first signature and the second signature for the generated heart signal. The processor compares the unique combination with the plurality of combinations in the database, locates a combination of the plurality of combinations that substantially matches the unique combination and generates a first indication if the unique combination substantially matches one of the first portion of the plurality of combinations and a second indication if the unique combination substantially matches one of the second portion of the plurality of combinations.

An apparatus device may include a bio-impedance sensor configured to take a bio-impedance measurement from a body of an individual, an optical sensor configured to take an optical measurement from the body of the individual, and a processing device configured to receive a first bio-impedance measurement from the bio-impedance sensor taken during a first period of time and a first optical measurement from the optical sensor taken during the first period of time, receive first location information of the individual during the first period of time, determine a first correlation between a physiological parameter and at least one of the first location, the first bio-impedance measurement, or the first optical measurement, and determine a first level of the physiological parameter based on the first correlation.

An apparatus device may include a bio-impedance sensor configured to take a bio-impedance measurement from a body of an individual, an optical sensor configured to take an optical measurement from the body of the individual, and a processing device configured to receive a first bio-impedance measurement from the bio-impedance sensor taken during a first period of time and a first optical measurement from the optical sensor taken during the first period of time, receive first location information of the individual during the first period of time, determine a first correlation between a physiological parameter and at least one of the first location, the first bio-impedance measurement, or the first optical measurement, and determine a first level of the physiological parameter based on the first correlation.

The invention provides a system and method for measuring vital signs (e.g. SYS, DIA, SpO2, heart rate, and respiratory rate) and motion (e.g. activity level, posture, degree of motion, and arm height) from a patient. The system features: (i) first and second sensors configured to independently generate time-dependent waveforms indicative of one or more contractile properties of the patient's heart; and (ii) at least three motion-detecting sensors positioned on the forearm, upper arm, and a body location other than the forearm or upper arm of the patient. Each motion-detecting sensor generates at least one time-dependent motion waveform indicative of motion of the location on the patient's body to which it is affixed. A processing component, typically worn on the patient's body and featuring a microprocessor, receives the time-dependent waveforms generated by the different sensors and processes them to determine: (i) a pulse transit time calculated using a time difference between features in two separate time-dependent waveforms, (ii) a blood pressure value calculated from the time difference, and (iii) a motion parameter calculated from at least one motion waveform.

The invention provides a system and method for measuring vital signs (e.g. SYS, DIA, SpO2, heart rate, and respiratory rate) and motion (e.g. activity level, posture, degree of motion, and arm height) from a patient. The system features: (i) first and second sensors configured to independently generate time-dependent waveforms indicative of one or more contractile properties of the patient's heart; and (ii) at least three motion-detecting sensors positioned on the forearm, upper arm, and a body location other than the forearm or upper arm of the patient. Each motion-detecting sensor generates at least one time-dependent motion waveform indicative of motion of the location on the patient's body to which it is affixed. A processing component, typically worn on the patient's body and featuring a microprocessor, receives the time-dependent waveforms generated by the different sensors and processes them to determine: (i) a pulse transit time calculated using a time difference between features in two separate time-dependent waveforms, (ii) a blood pressure value calculated from the time difference, and (iii) a motion parameter calculated from at least one motion waveform.

Aspects of the present disclosure provide a smart relaxation mask configured to output a stimulus and collect biometric information while the stimulus is output to determine if the subject is paying attention to the stimulus. If the subject is not focused on the stimulus, the mask adjusts at least one of an audio, visual, or haptic output. The stimulus is adjusted in an effort to shift the subject's attention to the stimulus and away from racing thoughts.

Aspects of the present disclosure provide a smart relaxation mask configured to output a stimulus and collect biometric information while the stimulus is output to determine if the subject is paying attention to the stimulus. If the subject is not focused on the stimulus, the mask adjusts at least one of an audio, visual, or haptic output. The stimulus is adjusted in an effort to shift the subject's attention to the stimulus and away from racing thoughts.

Numerous aspects of communication devices, methods, and systems are described in this application. One aspect is an apparatus comprising a plurality of energy generators arrangeable on or adjacent skin. Each energy generator of the plurality of energy generators may be operable to output a plurality of different energy types in a signal direction toward the skin. The plurality of energy generators may be operable to communicate with nerves associated with the skin when arranged on or adjacent the skin by outputting an energy signal in the signal direction with one or more energy types of the plurality of different energy types.

Techniques for wireless component monitoring are described herein. The techniques may include entering a low power mode to associate a radio frequency identification (RFID) component with a patient monitoring device within a first range. The techniques also include entering a high power mode wherein the patient monitoring device is to detect the RFID component within a second range of the patient monitoring device, wherein the second range is larger than the first range.

The present disclosure provides a method and system for estimating the clinical responsiveness of a patient to a dose of a plasminogen activating agent to treat a thrombosis, comprising determining a concentration of α2-antiplasmin in a blood sample of the patient, determining a concentration of activated fibrinolysis inhibitor (“TAFI”) in the blood sample, determining a concentration of plasminogen activator Inhibitor 1 (“PAI-1”) in the blood sample, computing a clot lysis time (“CLT”) based on the concentrations of a2-antiplasmin, TAFI and PAI-1 using the equation CLT=−2,813.6+31.1*a2-antiplasmin (percent activity)+31.1*TAFI (percent activity)+1.49 PAI-1 (ug/L), and determining that the patient is at increased risk of hemorrhage when the computed CLT is less than a first predetermined cutoff time.